HBI 2023

Wednesday June 21, 2023

2:30 pmSector Analysis

Opportunities in Oncology

There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.

Speakers include:

Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Nikos Paragios, CEO, TheraPanacea
Moderated by Joe Quiruga, Analyst, HBI

Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model

Dr Ralf Kurek
Dr Ralf KurekExecutive PartnerRadioOnkologieNetzwerk Ergéa Group
Ralph Hefti
Ralph HeftiCEOStingray Healthcare
Joe Quiruga
Joe QuirugaAnalystHBI
Nikos Paragios
Nikos ParagiosCEOTheraPanacea

Fleming - 3rd Floor

Read more

Explore similar sessions

Final discount saving ends in...


Thank you for your interest in the HBI 2023 conference!

The event has now concluded, however feel free to explore our past event and register your interest to stay tuned for updates on next year’s conference and exciting opportunities.

We appreciate your support and look forward to seeing you soon for HBI 2024.